Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy

Corrigendum: Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy

Bibliographic Details
Main Authors:	Zuhua Sun, Yuanyuan Gong, Yating Yang, Ying Huang, Suqin Yu, Junqing Pei, Bing Lin, Rong Zhou, Yingzi Li, Yumin Li, Junyan Zhang, Xiaoling Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Medicine
Subjects:	polypoidal choroidal vasculopathy photodynamic therapy conbercept non-inferiority efficacy
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.899310/full

Similar Items

Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy
by: Zuhua Sun, et al.
Published: (2022-02-01)

Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage
by: Jian Shen, et al.
Published: (2018-09-01)

Effect of intravitreal Conbercept on wet age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ying-Chun Li, et al.
Published: (2015-11-01)

Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept
by: Yin Xue, et al.
Published: (2022-02-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
by: Xiaoya Gu, et al.
Published: (2019-07-01)

Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
by: Yumiko Nakano, et al.
Published: (2018-01-01)

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
by: Marta Medina-Baena, et al.
Published: (2018-03-01)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019-05-01)

Comparison of the efficacy of two Conbercept regimens in the treatment of polypoid choroidal angiopathy
by: Zhou-Peng Liao, et al.
Published: (2020-03-01)

AFLIBERCEPT IN TREATMENT OF RESISTANT POLYPOID CHOROIDAL VASCULOPATHY: SHORT-TERM RESULTS
by: E. K. Pedanova, et al.
Published: (2017-12-01)

Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2021-01-01)

Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
by: Prashant Jain, et al.
Published: (2018-01-01)

Effect of Conbercept on treating polypoidal choroidal vasculopathy and its effect on hemorheology of patients
by: Ayinu·Nulahou, et al.
Published: (2020-04-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
by: Miyakubo T, et al.
Published: (2023-02-01)

Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regression
by: Junwoo Lee, et al.
Published: (2023-12-01)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
by: Colin S. Tan, MMed (Ophth), FRCOphth, et al.
Published: (2022-03-01)

Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
by: Kunbei Lai, et al.
Published: (2018-06-01)

Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches
by: Raymond L.M. Wong, et al.
Published: (2013-01-01)

Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy
by: Ryoh Funatsu, et al.
Published: (2024-04-01)

Observation of a pulsatile choroidal vascular lesion in a patient with polypoidal choroid vasculopathy during vitrectomy
by: Ting Zhang, et al.
Published: (2022-06-01)

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
by: Zafer Öztaş, et al.
Published: (2016-08-01)

Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports
by: Yasuhiro Iesato, et al.
Published: (2018-11-01)

CURRENT ASPECTS OF DIAGNOSIS AND TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY
by: A. V. Doga, et al.
Published: (2017-04-01)

Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review
by: Meng Zhao, et al.
Published: (2017-05-01)

Current management strategy of polypoidal choroidal vasculopathy
by: Christine P S Ho, et al.
Published: (2018-01-01)

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
by: Ratanasukon M, et al.
Published: (2018-10-01)

Comparison of intravitreal bevacizumab to photodynamic therapy for polypoidal choroidal vasculopathy: Short-term results
by: Mitamura Yoshinori, et al.
Published: (2010-01-01)

Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
by: Yukinori Sakaeda, et al.
Published: (2023-07-01)

Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy:a systematic review and Meta-analysis
by: Kai Tang, et al.
Published: (2015-10-01)

Choroidal nevus and polypoidal vasculopathy: case series
by: Karlos Ítalo S. Viana, et al.
Published: (2020-06-01)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
by: Dimitrios A Karagiannis, et al.
Published: (2009-06-01)

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy; A Real Life Experience
by: Sibel Ahmet, et al.
Published: (2017-12-01)

The Association of Pachydrusen Characteristics with Choroidal Thickness and Patient’s Age in Polypoidal Choroidal Vasculopathy versus Central Serous Chorioretinopathy
by: Young Ho Kim, et al.
Published: (2022-07-01)

Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a Meta-analysis
by: Long-Hui Han1, et al.
Published: (2017-08-01)

Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
by: Aditya Bansal, et al.
Published: (2017-01-01)

Systemic Risk Factors for Vitreous Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
by: Baoyi Liu, et al.
Published: (2023-08-01)